Montreal, September 27, 2011 – Following approval by the World Anti-Doping Agency's (WADA) Executive Committee on September 17, the 2012 List of Prohibited Substances and Methods is now available.

Noteworthy changes to the List, which will come into force on January 1, 2012, include:

Formoterol added as an exception to beta-2 agonists
One of the most significant changes is the removal of formoterol from Section 3 ‘Beta-2 Agonists’ of the List when taken by inhalation at therapeutic dosages.

Following its approval by the World Anti-Doping Agency's (WADA) Executive Committee on September 18, the 2011 List of Prohibited Substances and Methods is now available. This List will take effect on January 1, 2011.

Noteworthy changes compared to the 2010 List include:

Non-Approved Substances
A new section – “Non-Approved Substances” – has been added. This “open” section addresses the abuse of pharmacological substances for the purpose of performance enhancement which are not included in other sections of the List and which are not approved by any governmental regulatory health authority for human therapeutic use (i.e. drugs under pre-clinical or clinical development or discontinued).

Platelet-Derived Preparations
Platelet-derived preparations (commonly referred as PRP or blood spinning), prohibited in 2010 when administered by intra-muscular route, have been removed from the List for 2011 after consideration of the lack of current evidence concerning the use of these methods for purposes of performance enhancement. Current studies on platelet-derived preparations do not demonstrate a potential for performance enhancement beyond a potential therapeutic effect.

Australian International Shooting Limited has a strong view on drugs in sport and the Policy controlling this is the WADA compliant AISL - Anti-Doping Policy. The latest from ISSF re: ATUEs  /  TUE Changes  /  Declaration of Use

Note: that ISSF's anti doping policy does not include a mutual recognition clause. ISSF's anti doping policy overrules AISL's anti doping policy. International competitors who may be subject to ISSF rules of the conflict in conditions and that the ISSF anti doping policy does not include a mutual recognition clause but in fact requires that ISSF consider all TUE applications for all international athletes competing at ISSF events (clause 5.5.3.2).

• Athlete Whereabouts Form
• Athlete Whereabouts Bulletin (Information)
• Athlete Anti Doping Info (ASADA site)
  
  

Travel Thoughts

Those intending to compete internationally should be aware of the following information. As always this is general advice and should be discussed with your personal doctor, bearing in mind the use of prescription drugs.

Travel Requirements

Whilst travelling it is a requirement that the airline and possibly the country you are passing through and to, may require notification of your carriage of target guns. In all cases check with the airline and/or travel agent as to what is required. Those travelling as a Team should check with their Manager.